According to Grifols's latest financial reports the company has $9.05 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $9.05 B | 9.31% |
2021-12-31 | $8.28 B | 0.25% |
2020-12-31 | $8.26 B | 7.78% |
2019-12-31 | $7.66 B | 42.73% |
2018-12-31 | $5.37 B | 23.16% |
2017-12-31 | $4.36 B | 11.16% |
2016-12-31 | $3.92 B | 8.72% |
2015-12-31 | $3.60 B | 11.46% |
2014-12-31 | $3.23 B | 11.29% |
2013-12-31 | $2.91 B | 16.97% |
2012-12-31 | $2.48 B | 15.29% |
2011-12-31 | $2.15 B | 129.33% |
2010-12-31 | $0.94 B | 13.52% |
2009-12-31 | $0.82 B | 23.19% |
2008-12-31 | $0.67 B | 19.95% |
2007-12-31 | $0.56 B | 15.2% |
2006-12-31 | $0.48 B | 636.51% |
2005-12-31 | $66.11 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $68.77 B | 659.68% | ๐บ๐ธ USA |
Amgen AMGN | $6.23 B | -31.16% | ๐บ๐ธ USA |
Baxter BAX | $8.46 B | -6.46% | ๐บ๐ธ USA |
Kimberly-Clark KMB | $1.06 B | -88.20% | ๐บ๐ธ USA |